TrialCirculation2021

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).

Matthew M Y Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.